65,437 trials
Aortic Stenosis
Primary: Number of Self-Centering Guide Catheters Successfully Used to Deliver a Guide Wire Through the Self-Centering Guide Catheter Across the Stenotic Native Aortic Valve Into…
PTSD · Addiction
Primary: PTSD Symptoms — 38.7; 52.8; 32.0; 51.5 units on a scale
Ulcers · Bedsores
Primary: Pressure Mapping Reducing Hospital Acquired Pressure Ulcers — 2; 10 Participants
Furunculosis
Primary: Number of Side-effects — 4; 2 Participants
X-linked Adrenoleukodystrophy
Primary: Change in Maximal Voluntary Contraction of the Hip Flexors From Baseline to End of Training and to Post-training — 0.94; 0.98; 1.32; 1.37 kg
Asthma
Primary: Level of Tumour Necrosis Factor-alpha (TNF-α) in Blood at Baseline (Visit 1) — 5.3; 9.3; 10.6; 15.7 pg/mL
Refractory Partial Seizures
Primary: Number of Participants With Treatment-Emergent Adverse Events (TEAEs) and Serious Adverse Events (SAEs) as a Measure of Safety and Tolerability of Perampanel — 21; 11…
Adverse Drug Events · Adverse Drug Reactions · Drug Interaction Potentiation
Primary: Number of Re-hospitalizations at 30 and 60 Days — 0.38; 0.25; 0.7; 0.33 Re-hospitalizations — p=0.21
Prostate Cancer
Primary: Proportion of Patients P0 at Surgery — 0 Participants
Hormone-sensitive, HER-2 Negative Metastatic Breast Cancer
Primary: Phase 1b and Phase 2: Number of Participants With Treatment Emergent Adverse Events (TEAEs) and Treatment Emergent Serious Adverse Events (TESAEs) — 3; 3; 90; 82…
Cervical Adenocarcinoma · Cervical Adenosquamous Carcinoma · Cervical Squamous Cell Carcinoma
Primary: Duration of Overall Survival (OS) — 12.87; 9.99; 10.28; 10.25 months
Adult Solid Neoplasm · Lymphoma
Primary: Direct Communication About Age-related Concerns: Number of Discussions Related to the Geriatric Assessment That Occur in the Clinic Visit Between the Patient, Oncology…
HIV
Primary: Grade 1 Genitourinary Events or Higher as Defined by the DAIDS Table for Grading the Severity of Adult and Pediatric Adverse Events — 7; 1 Adverse events
Growth and Development
Primary: Incremental Area Under the Curve to 24 Hours (h) (iAUC0-24h) of the Sum of Plasma Total and Free n-3 Fatty Acids (Docosahexaenoic Acid (DHA) and Eicosapentaenoic Acid…
Asthma
Primary: Change From Baseline in Fraction of Exhaled Nitric Oxide (FeNO) Over Time Following the Cessation of Repeat Dose Treatment With FF/VI — 1.042; 0.371; 0.985; 0.321 Ratio…